☆ 3.9 Article

Epicutaneous and sublingual immunotherapy: Efficacy, tolerance and place in the management of food allergy

REVUE FRANCAISE D ALLERGOLOGIE (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Allergy

Oral immunotherapy for food allergy: Translation from studies to clinical practice?

Guillaume Pouessel et al.

Summary: Oral immunotherapy (OIT) is an alternative treatment for patients with IgE-mediated food allergies, and studies have confirmed its efficacy in desensitizing children to common allergens. However, there is still a lack of consensus on patient selection for OIT and many issues, such as long-term efficacy and patient experience, need to be addressed. The recent authorization of the first peanut OIT medicine is a step towards standardization in OIT practice. This article provides a comprehensive summary of the data on OIT efficacy, tolerance, quality of life, and adverse effects, as well as discussing important considerations for clinical practice.

WORLD ALLERGY ORGANIZATION JOURNAL (2023)

添加到收藏夹

Article Allergy

Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children

Marie Bastin et al.

Summary: This study examined the serum-specific IgG4 and IgE levels in peanut-allergic children receiving Viaskin Peanut treatment, and found that IgG4 rise most clearly differentiated treatment responders from non-responders. IgG4/IgE ratios >20.1 and the combination of Ara h 1 and peanut IgG4/IgE showed moderate ability to predict treatment response.

ALLERGY (2023)

添加到收藏夹

Article Allergy

Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children

Edwin H. Kim et al.

Summary: This study evaluated the efficacy and safety of 4-mg peanut sublingual immunotherapy (SLIT) and the persistence of desensitization after discontinuation of SLIT. The results showed that most children achieved significant desensitization during SLIT and it lasted for more than 17 weeks after discontinuation. This study demonstrates that peanut SLIT is safe and effective.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy

M. Greenhawt et al.

Summary: This study found that epicutaneous immunotherapy using a peanut patch can effectively reduce symptoms and increase tolerance to peanuts in children aged 1 to 3 years with peanut allergy.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

添加到收藏夹

Article Allergy

Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial

Edwin H. Kim et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of oral immunotherapy in children aged 1–3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study

Stacie M Jones et al.

LANCET (2022)

添加到收藏夹

Article Allergy

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

Jacqueline A. Pongracic et al.

Summary: In a study designed to mimic real-world use, VP250 was found to be well tolerated in peanut-allergic children, consistent with previous research.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

添加到收藏夹

Article Allergy

Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets

Leo Laoubi et al.

Summary: This study investigates the phenotype and functional characteristics of skin dendritic cells (skDCs) during epicutaneous immunotherapy (EPIT), finding that skDCs gradually change their phenotype and functional properties during EPIT, which is crucial for achieving desensitization.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

添加到收藏夹

Article Nutrition & Dietetics

Prevalence of Food Allergy in France up to 5.5 Years of Age: Results from the ELFE Cohort

Sarah Tamazouzt et al.

Summary: This study evaluated the prevalence of food allergies in children in France and identified the most common allergens. It was found that 1 in 5 children with allergies had multiple food allergies. The study demonstrated that the prevalence of food allergies in children up to 5.5 years of age in France is approximately 6%.

NUTRIENTS (2022)

添加到收藏夹

Review Allergy

Mast Cell Desensitization in Allergen Immunotherapy

Celia Lopez-Sanz et al.

Summary: Allergen immunotherapy (AIT) is the only treatment with disease-transforming potential for allergic disorders. The immunological mechanisms associated with AIT can be divided into short-term and long-term phases. MC desensitization occurs in the short-term phase and is often related to the success of AIT. The major challenges of AIT include its long duration, the development of allergic reactions, and the lack of efficacy in a considerable proportion of patients. Understanding the immunology of AIT can help address these issues and predict responder-patients. Omics strategies can aid in the identification of predictive and follow-up biomarkers for AIT.

FRONTIERS IN ALLERGY (2022)

添加到收藏夹

Letter Allergy

Sustained unresponsiveness to peanut after long-term peanut epicutaneous immunotherapy

Terri F. Brown-Whitehorn et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

添加到收藏夹

Letter Allergy

Sustained milk consumption after 2 years post-milk epicutaneous immunotherapy for eosinophilic esophagitis

Jonathan M. Spergel et al.

ALLERGY (2021)

添加到收藏夹

Review Pediatrics

Oral immunotherapy in food allergies: A practical update for pediatricians

M. Sabouraud et al.

Summary: FA-OIT is a promising treatment for persistent and severe food allergies in children, aiming to increase the reactive threshold of allergic patients to enable them to ingest a target quantity of allergen without reaction. While successful in desensitization, the treatment also presents side effects and safety concerns, necessitating patient and family training to manage reactions.

ARCHIVES DE PEDIATRIE (2021)

添加到收藏夹

Review Immunology

Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate

Francesca Mori et al.

Summary: The prevalence of food allergy, especially in children, has been increasing in recent years. Oral immunotherapy (OIT) has gained attention as a potential treatment for food allergy, with a focus on desensitization, however, there is still no definitive conclusion on its efficacy.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Allergy

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy

Philippe Begin et al.

ALLERGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Efficacy of Epicutaneous Immunotherapy in Children With Milk-Induced Eosinophilic Esophagitis

Jonathan M. Spergel et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Article Allergy

Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results

David M. Fleischer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Editorial Material Allergy

Food oral immunotherapy is superior to food avoidance-CON

Camille Braun et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy The PEPITES Randomized Clinical Trial

David M. Fleischer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

添加到收藏夹

Article Environmental Sciences

The Epidemiology of Food Allergy in the Global Context

Wenyin Loh et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2018)

添加到收藏夹

Article Immunology

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice

Vincent Dioszeghy et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Medicine, General & Internal

Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity A Randomized Clinical Trial

Hugh A. Sampson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Article Allergy

Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective

Brian P. Vickery et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

添加到收藏夹

Article Allergy

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy

Satya D. Narisety et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

添加到收藏夹

Article Allergy

Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial

A. Wesley Burks et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

添加到收藏夹

Article Allergy

EAACI Food Allergy and Anaphylaxis Guidelines. Protecting consumers with food allergies: understanding food consumption, meeting regulations and identifying unmet needs

A. Muraro et al.

ALLERGY (2014)

添加到收藏夹

Article Allergy

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation

Abel Suarez-Fueyo et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

添加到收藏夹

Article Allergy

Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo-controlled multicenter trial

David M. Fleischer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

添加到收藏夹

Article Allergy

The safety and efficacy of sublingual and oral immunotherapy for milk allergy

Corinne A. Keet et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

添加到收藏夹

Meeting Abstract Allergy

Early and Persistent Gastrointestinal Side Effects Predict Withdrawal from Peanut Oral Immunotherapy (OIT)

B. P. Vickery et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

添加到收藏夹

Meeting Abstract Allergy

Evidence of Desensitization by Sublingual Immunotherapy in Peanut-Allergic Children

E. H. Kim et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

添加到收藏夹

Article Immunology

Epicutaneous Immunotherapy Results in Rapid Allergen Uptake by Dendritic Cells through Intact Skin and Downregulates the Allergen-Specific Response in Sensitized Mice

Vincent Dioszeghy et al.

JOURNAL OF IMMUNOLOGY (2011)

添加到收藏夹

Article Allergy

Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells

G. W. Scadding et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2010)

添加到收藏夹

Letter Allergy

Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity

Christophe Dupont et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)

添加到收藏夹

Letter Allergy

Sublingual immunotherapy for hazelnut food allergy: A follow-up study

Ernesto Enrique et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2008)

添加到收藏夹

Article Allergy

Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells

Jean-Pierre Allam et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.